The connective tissue changes of Crohn's disease

Histopathology

Volumn 60, Issue 7, 2012, Pages 1034-1044

  Shelley Fraser, Golda ^a   Borley, Neil R ^a   Warren, Bryan F ^b   Shepherd, Neil A ^a  

^a CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Crohn's disease; Fat wrapping; Fibrosis; Muscularization; Neuronal hyperplasia; Vascular changes

Indexed keywords

COLLAGEN TYPE 3; FAT;

ADIPOCYTE; BLOOD VESSEL REACTIVITY; CELL PROLIFERATION; CELL STRUCTURE; CONNECTIVE TISSUE; CORRELATION ANALYSIS; CROHN DISEASE; DIAGNOSTIC REASONING; DIGESTIVE TRACT BLOOD VESSEL; FIBROSIS; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; NEURONAL HYPERPLASIA; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE; TISSUE EXPANSION; ULCER;

ADIPOKINES; ADIPOSE TISSUE; COLLAGEN; CONNECTIVE TISSUE; CROHN DISEASE; FIBROSIS; HUMANS; INFLAMMATION; INTESTINES; LIPID METABOLISM; MUSCLE, SMOOTH;

EID: 84861478297     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03911.x     Document Type: Review

References (83)

1. Day DW, Jass JR, Price AB et al. Inflammatory disorders of the small intestine. In Day DW, Jass JR, Price AB et al. eds. Morson and Dawson's gastrointestinal pathology, 4th edn. Oxford: Blackwell Scientific, 2003; 272-323.
2. Borley NR, Mortensen NJ, Jewell P, Warren BF. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link. J. Pathol. 2000; 190; 196-202.
3. Chambers TJ, Morson BC. The granuloma in Crohn's disease. Gut 1979; 20; 269-274.
4. Sheehan AL, Warren BF, Gear MW, Shepherd NA. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br. J. Surg. 1992; 79; 955-958.
5. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S. Cytokine production in patients with inflammatory bowel disease. Gut 1992; 33; 933-937.
6. Mahida YR, Kurlac L, Gallagher A, Hawkey CJ. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 1991; 32; 1531-1534.
7. Stevens C, Walz G, Singaram C et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig. Dis. Sci. 1992; 37; 818-826.
8. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992; 339; 89-91.
9. Pond CM. Long-term changes in adipose tissue in human disease. Proc. Nutr. Soc. 2001; 60; 365-374.
10. Schaffer A, Herfarth H. Creeping fat in Crohn's disease: travelling in a creeper lane of research? Gut 2005; 54; 742-744.
11. Peyrin-Biroulet L, Chamaillard M, Gonzalez F et al. Mesenteric fat in Crohn's disease: a pathogenic hallmark or an innocent bystander. Gut 2007; 56; 577-583.
12. Lehrke M, Lazar MA. Inflamed about obesity. Nat. Med. 2004; 10; 126-127.
13. Kern PA, Saghizadeh M, On JM, Bosch RJ, Deem R, Sisal RB. The expression of tumour cell necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipase. J. Clin. Invest. 1995; 95; 211-219.
14. Charriere G, Cousin B, Arnaud E et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem. 2003; 278; 9850-9855.
15. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 2000; 11; 327-332.
16. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004; 84; 2548-2556.
17. Rajala MW, Scherer PE. The adipocyte-at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 2003; 144; 3765-3773.
18. Mohamed-Ali V, Pinkley JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int. J. Obes. Relat. Metab. Disord. 1998; 22; 1145-1158.
19. Pond CM. Physiological specialisation of adipose tissue. Prog. Lipid Res. 1999; 38; 225-248.
20. Pantanetti P, Garrapa GG, Mantero F, Boscaro M, Faloia E, Venarucci D. Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunction Clin. Exp. Hypertens. 2004; 26; 387-398.
21. Lyon CJ, Law RE, Hsueh WA. Adiposity, inflammation and atherogenesis. Endocrinology 2003; 144; 2195-2200.
22. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 2004; 92; 347-355.
23. Trayhurn P. The biology of obesity. Proc. Nutr. Soc. 2005; 64; 31-38.
24. Sadler D, Mattacks CA, Pond CM. Changes in adipocytes and dendritic cells in lymph node containing adipose depots during and after many weeks of mild inflammation. J. Anat. 2005; 207; 769-781.
25. Fazio VW. The surgery of Crohn's disease of the small bowel. In Allan RN, Keighley MR, Alexander Williams J, Hawkins C eds. Inflammatory bowel disease. Edinburgh: Churchill Livingstone, 1983; 452-461.
26. Westcott EDA, Windsor ACJ, Mattacks CA, Pond CM, Knight SC. The fatty acid compositions of lipids in mesenteric adipose tissue and lymphoid cell in patients with and without Crohn's disease and their therapeutic implications. Inflamm. Bowel Dis. 2005; 11; 820-827.
27. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a clinical and pathological entity. JAMA 1932; 99; 1323-1329.
28. Pond CM. Adipose tissue and the immune system. Prostaglandins Leukot. Essent. Fatty Acids 2005; 73; 17-30.
29. Westcott ED, Mattacks CA, Windsor AC, Knight SC, Pond CM. Perinodal adipose tissue and fatty acid composition of lymphoid tissue in patients with and without Crohn's disease and their implications for the etiology and treatment of CD. Ann. N Y Acad. Sci. 2006; 1072; 395-400.
30. Geerling BJ, van Houwelingen AC, Badart-Smook A, Stockbrugger RW, Brummer JM. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am. J. Gastroenterol. 1999; 94; 410-417.
31. Dubuquoy L, Dharancy S, Nutten S, Pettersson S, Auxerx J, Desreumaux P. Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological disease. Lancet 2002; 360; 1410-1418.
32. Desreumaux P, Ernst O, Geboes K et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999; 117; 73-81.
33. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int. J. Biochem. Cell Biol. 1998; 30; 909-922.
34. Ouchi N, Kihara S, Arita Y et al. Adiponectin, adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signalling through Camp-dependent pathways. Circulation 2000; 102; 1296-1301.
35. Yamamato K, Kioyara T, Murayama Y. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 2005; 54; 789-796.
36. Shimomura I, Funahashi T, Takahashi M et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 1996; 2; 800-803.
37. Murch SH, Braegger CP, Walker-Smith JA, McDonald TT. Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993; 34; 1705-1709.
38. Weisburg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003; 112; 1796-1808.
39. Shepherd NA, Jass JR. Neuromuscular and vascular hamartoma of the small intestine: is it Crohn's disease? Gut 1987; 28; 1663-1668.
40. Koukoulis G, Ke Y, Henley JD, Cummings OW. Obliterative muscularization of the small bowel submucosa in Crohn's disease. A possible mechanism of small bowel obstruction. Arch. Pathol. Lab. Med. 2001; 125; 1331-1334.
41. Tanaka M, Riddell RH. The pathological diagnosis and differential diagnosis of Crohn's disease. Hepatogastroenterology 1990; 37; 18-31.
42. Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990; 343; 82-85.
43. Borley N, Mortensen N, Kettlewell M, George BD, Jewell DP, Warren BF. Connective tissue changes in ileal Crohn's disease: relationship to disease phenotype and ulcer-associated cell lineage. Dis. Colon Rectum 2001; 44; 388-396.
44. Graham MF, Drucker DE, Deigelmann RF, Elson CO. Collagen synthesis by human intestinal smooth muscle cells in culture. Gastroenterology 1987; 93; 400-405.
45. Feldman M, Scharschmidt BF, Sleisinger MH. Crohn's disease. In Feldman M, Scharschmidt BF, Sleisinger MH eds. Sleisinger and Fordtran's gastrointestinal and liver disease, 6th edn. Philadelphia, PA: WB Saunders, 1998; 1708-1734.
46. Harper PH, Fazio VW, Lavery IC et al. The long-term outcome in Crohn's disease. Dis. Colon Rectum 1987; 30; 174-179.
47. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88; 1818-1825.
48. Wettergren A, Christiansen J. Risk of recurrence and re-operation after resection for ileocolic Crohn's disease. Scand. J. Gastroenterol. 1991; 26; 1319-1322.
49. Fazio VW, Marchetti F. Recurrent Crohn's disease and resection margins: bigger is not better. Adv. Surg. 1999; 32; 135-168.
50. Fenoglio-Preiser CM, Noffsinger A, Stemmermann GN, Lantz PE, Isaacson PG. Inflammatory bowel disease. In Fenoglio-Preiser CM, Noffsinger A, Stemmermann GN, Lantz PE, Isaacson PG eds. Gastrointestinal pathology: an atlas and text, 3rd edn. Philadelphia, PA: Lippincott, Williams and Wilkins, 2008; 593-690.
51. Kelly JK, Sutherland LR. The chronological sequence in the pathology of Crohn's disease. J. Clin. Gastroenterol. 1988; 10; 28-33.
52. Kelly JK, Siu TO. The strictures, sinuses and fissures of Crohn's disease. J. Clin. Gastroenterol. 1986; 8; 594-598.
53. Lawrance IC. Connective tissue responses. In Fraser A, Gibson PR, Hibi T, Qian J-M, Scholmerich J eds. Emerging issues in inflammatory bowel disease, Falk Symposium 151. Berlin: Springer, 2006; 103-117.
54. Sidham VB, Komorowski R, Asma Z et al. Histomorphologic changes in patients presenting with obstruction secondary to infliximab therapy in Crohn's disease(abstract 547). Mod. Pathol. 2001; 14; 95A.
55. Ghadially FN. Ultrastructural pathology of the cell. London: Butterworth, 1975.
56. Carr IC, Toner PG. Cell structure-an introduction to biomedical electron microscopy. London: Churchill Livingstone, 1982.
57. Schurch W, Seemayer TA, Gabbiani G. Myofibroblast. In Sternberg SS ed. Histology for pathologists, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1997; 129-166.
58. Goldberg B, Green H. An analysis of collagen secretion by established mouse fibroblast lines. J. Cell Biol. 1964; 22; 227-258.
59. Graham MF, Diegelmann RF, Elson CO et al. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 1988; 94; 257-265.
60. Kjeldsen J, Schaffalitzky de Muckadell OB, Junker P. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. Gut 1995; 37; 805-810.
61. Wegrowski J, Lafuma C, Lefaix J, Daburon F, Robert L. Modification of collagen and non-collagenous proteins in radiation-induced muscular fibrosis. Exp. Mol. Pathol. 1988; 48; 273-285.
62. Tonelli F, Ficari F. Strictureplasty in Crohn's disease: surgical options. Dis. Colon Rectum 2000; 43; 920-926.
63. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe Seyler 1995; 376; 345-355.
64. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ, Nash GS. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 1991; 101; 1020-1030.
65. van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut 1997; 40; 443-448.
66. Bird JL, Tyler JA. Tumour necrosis factor alpha, interferon gamma and dexamethasone regulate IGF-I-maintained collagen production in cultured human fibroblasts. J. Endocrinol. 1995; 147; 167-176.
67. Targan SR, Hanauer SB, van Deventer SJ et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N. Engl. J. Med. 1997; 337; 1029-1035.
68. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 1991; 174; 1549-1555.
69. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivation factor and transforming growth factors-beta1, beta-2 and beta3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J. Immunol. 1990; 145; 940-944.
70. Whitehead R. Pathology of Crohn's disease. In Kirsner JB, Shorter RG eds. Inflammatory bowel disease, 2nd edn. Philadelphia, PA: Lea & Febiger, 1980; 296-307.
71. Davies DR, Dockerty MB, Mayo CW. The myenteric plexus in regional enteritis. A study of the number of ganglion cells in the ileum in 24 cases. Surg. Gynecol. Obstet. 1955; 10; 208-213.
72. Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S. Abnormalities of vaso-active intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology 1980; 79; 853-860.
73. Leonard N, Hourihane DO, Whelan A. Neuroproliferation in the mucosa is a feature of coeliac disease and Crohn's disease. Gut 1995; 37; 763-765.
74. Fernando SS, McGovern VJ. Neuromuscular and vascular hamartoma of small bowel. Gut 1982; 23; 1008-1012.
75. Smith CE, Filipe MI, Owen WJ. Neuromuscular and vascular hamartoma of small bowel presenting as inflammatory bowel disease. Gut 1986; 27; 964-969.
76. Wakefield AJ, Sawyerr AM, Dhillon AP et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 2; 1057-1062.
77. Knutson H, Lunderquist A. Vascular changes in Crohn's disease. Am. J. Roentgenol. Radium Ther. Nucl. Med. 1968; 103; 380-385.
78. Rice AJ, Abbott CR, Mapstone NM. Granulomatous vasculitis in diversion proctocolitis. Histopathology 1999; 34; 276-277.
79. Desreumaux P, Huet G, Zerimech F et al. Acute inflammatory intestinal vascular lesions and in situ abnormalities of the plasminogen activation system in Crohn's disease. Eur. J. Gastroenterol. Hepatol. 1999; 11; 1113-1119.
80. Lorenzo GA, Poticha SM, Beal JM. Mesenteric lymphatics in regional enteritis. Arch. Surg. 1972; 105; 375-378.
81. Mooney EE, Walker J, Hourihane DO. Relation of granulomas to lymphatic vessels in Crohn's disease. J. Clin. Pathol. 1995; 48; 335-338.
82. Alexander JS, Chaitanya GV, Grisham MB, Boktor M. Emerging roles of lymphatics in inflammatory bowel disease. Ann. N. Y. Acad. Sci. 2010; 1207(Suppl. 1); E75-E85.
83. Linares PM, Gisbert JP. Role of growth factors in the development of lymphangiogenesis driven by inflammatory bowel disease: a review. Inflamm. Bowel Dis. 2011; 17; 1814-1821.